Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Newborn Screening Market Size, Share & Trends Analysis Report by Product (Instruments and Reagents & Assay Kits), Technology (Tandem Mass...
-
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
-
Chicago, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The global single-use bioprocessing market reached a valuation of USD 30.12 billion in 2025 and is forecasted to expand to USD 122.92 billion by 2035,...
-
Dublin, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The "Aircraft Black Box Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Aircraft Black Box Market expanded...
-
Aquaculture Vaccine Market Set to Nearly Double by 2033, Driven by Rising Disease Prevention Efforts
Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "Aquaculture Vaccines Market Size, Share & Trends Analysis Report by Product (Attenuated Live Vaccines, Inactivated Vaccines), Route of...
-
Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "AI in Drug Discovery Market, till 2040: Distribution by Drug Discovery Steps, Therapeutic Area, and Key Geographical Regions: Industry Trends and...
-
Dublin, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The "Topiramate Drugs Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Topiramate Drugs Market experienced...
-
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds
-
Chicago, Jan. 13, 2026 (GLOBE NEWSWIRE) -- The global artificial insemination market was valued at 2.8 billion in 2024 and is expected to reach US$ 5.5 billion by 2033, growing at a CAGR of 7.9%...
-
Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both treatment-naïve and previously-treated nusinersen patients with SMA1Biogen...